Skip to main content
Clinical Trials/NCT00512551
NCT00512551
Completed
Not Applicable

A Pilot Study of Early Changes in DNA Array Expression Following Chemo-Radiation Treatment of Cervical Cancer

M.D. Anderson Cancer Center1 site in 1 country18 target enrollmentJune 20, 2000
ConditionsCervical Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cervical Cancer
Sponsor
M.D. Anderson Cancer Center
Enrollment
18
Locations
1
Primary Endpoint
The goal of this clinical research study is to find out if the expression of certain genes is linked with the response of cervical cancer to radiation.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The goal of this clinical research study is to find out if the expression of certain genes is linked with the response of cervical cancer to radiation. Researchers will study a large number of genes located in tumor material to learn this information.

Detailed Description

Patients in this study are already scheduled to begin radiation therapy. Researchers will get tumor cells by taking two biopsies of the cervix. The first biopsy of the cervical tumor will be done before any treatment is given. The second biopsy will be performed about 48 hours after the radiation treatment has begun. They will then study the cells in the lab with a new technique for studying gene expression called DNA array, as well as human papillomavirus (HPV) analysis, quantification of apoptosis levels, hematoxylin and eosin staining, and storage of tissue for future research. The patterns of gene expression in the biopsies will be compared with the success of radiation treatments. Some of the material will also be stored and used in the future for other research projects. This is an investigational study. A total of 18 patients will take part in this study. All will be enrolled at UTMDACC.

Registry
clinicaltrials.gov
Start Date
June 20, 2000
End Date
November 20, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosed cervical cancer: clinical Stage IB -IIIB
  • Invasive pure squamous cell carcinoma
  • Planned treatment with concurrent cisplatinum/5-fluorouracil chemotherapy and pelvic radiation

Exclusion Criteria

  • Previous cervical cancer treatment including but not limited to transvaginal cone irradiation

Outcomes

Primary Outcomes

The goal of this clinical research study is to find out if the expression of certain genes is linked with the response of cervical cancer to radiation.

Time Frame: 8 Years

Secondary Outcomes

  • Researchers will study a large number of genes located in tumor material to learn this information.(8 Years)

Study Sites (1)

Loading locations...

Similar Trials